Project/Area Number |
26461868
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Radiation science
|
Research Institution | Nara Medical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
平井 都始子 奈良県立医科大学, 医学部, 病院教授 (00208802)
田中 利洋 奈良県立医科大学, 医学部, 准教授 (70326338)
|
Co-Investigator(Renkei-kenkyūsha) |
HIRAI Toshiko 奈良県立医科大学, 医学部, 病院教授 (00208802)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2014: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | chemoemboliztaion / liver cancer / マイクロスフィア / ビーズ / インターベンショナルラジオロジー(IVR) / インターベンショナルラジオロジー(IVR) |
Outline of Final Research Achievements |
Transarterial chemoembolization (TACE) is widely used for unresectable hepatocellular carcinoma. Recently, TACE using microspheres has been developed. In this study, in a rabbit liver tumor model, TACE using microspheres was evaluated. When comparing TACE using starch microspheres mixed with cisplatin arterial infusion, TACE was superior in the tumor drug concentration and the efficacy. In addition, microspheres dissolved within 24 hours.
|